Angiodynamics (ANGO) Shares Outstanding (2010 - 2026)
Angiodynamics' (ANGO) quarterly Shares Outstanding (Entity) came in at $42.3 million in Q2 2026, up 1.7% YoY from $41.6 million in Q2 2025, and little changed on a QoQ basis from $42.3 million in Q1 2026.
Angiodynamics (ANGO) Shares Outstanding (2010 - 2026) Analysis & Trends
Angiodynamics (ANGO) has 17 years of Shares Outstanding (Entity) data on file, last reported at $42.3 million in Q2 2026.
- Quarterly Shares Outstanding (Entity) rose 1.7% year-over-year to $42.3 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $42.3 million (up 1.7% YoY) and the FY2026 annual result came in at $42.3 million, up 1.7% from the prior year.
- Shares Outstanding (Entity) held at $42.3 million in Q2 2026, from $42.3 million in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $42.3 million in Q2 2026 to a low of $39.1 million in Q1 2022.
- A 5-year average of $40.9 million and a median of $40.8 million in 2024 frame the typical range for Shares Outstanding (Entity).
- The widest YoY moves for Shares Outstanding (Entity): up 3.13% in 2022, down 0.55% in 2022.
- Tracing ANGO's Shares Outstanding (Entity) over 5 years: stood at $39.9 million in 2022, then gained by 1.81% to $40.6 million in 2023, then increased by 2.11% to $41.4 million in 2024, then increased by 1.78% to $42.2 million in 2025, then advanced by 0.3% to $42.3 million in 2026.
- The last three Shares Outstanding (Entity) figures came in at $42.3 million (Q2 2026), $42.3 million (Q1 2026), and $42.2 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 135.04 Bn | 129.82 Bn | 1.96 Bn | 354.10 Mn |
| 2 | Becton Dickinson | 52.58 Bn | 51.72 Bn | 2.32 Bn | 274.79 Mn |
| 3 | Alcon | 35.77 Bn | 34.41 Bn | 1.68 Bn | 486.70 Mn |
| 4 | Resmed | 33.99 Bn | 32.52 Bn | 861.22 Mn | 145.52 Mn |
| 5 | Medline | 29.05 Bn | 26.38 Bn | 2.22 Bn | 857.00 Mn |
| 6 | West Pharmaceutical Services | 24.96 Bn | 24.52 Bn | 329.20 Mn | 70.80 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 172.70 Mn |
| 8 | Cooper Companies | 14.85 Bn | 14.71 Bn | 735.40 Mn | 195.00 Mn |
| 9 | Baxter International | 13.66 Bn | 11.51 Bn | 1.03 Bn | 517.00 Mn |
| 10 | Angiodynamics | 654.45 Mn | 600.59 Mn | 46.77 Mn | 41.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 41.53 Mn |
| Feb 28, 2026 | 41.60 Mn |
| Nov 30, 2025 | 41.54 Mn |
| Aug 31, 2025 | 41.17 Mn |
| May 31, 2025 | 40.85 Mn |
| Feb 28, 2025 | 40.85 Mn |
| Nov 30, 2024 | 40.92 Mn |
| Aug 31, 2024 | 40.65 Mn |
| May 31, 2024 | 40.18 Mn |
| Feb 29, 2024 | 40.23 Mn |
| Nov 30, 2023 | 40.22 Mn |
| Aug 31, 2023 | 39.84 Mn |
| May 31, 2023 | 39.48 Mn |
| Feb 28, 2023 | 39.51 Mn |
| Nov 30, 2022 | 39.49 Mn |
| Aug 31, 2022 | 39.30 Mn |
| May 31, 2022 | 39.01 Mn |
| Feb 28, 2022 | 39.09 Mn |
| Nov 30, 2021 | 39.05 Mn |
| Aug 31, 2021 | 38.73 Mn |